Ovid Therapeutics Inc. (NASDAQ: OVID) started the day on June 29, 2020, with a price decrease of -0.39% at $7.68. During the day, the stock rose to $8.0193 and sunk to $7.44 before settling in for the price of $7.71 at the close. Taking a more long-term approach, OVID posted a 52-week range of $1.74-$9.40.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 26.90%. This publicly-traded company’s shares outstanding now amounts to $54.72 million, simultaneously with a float of $32.76 million. The organization now has a market capitalization sitting at $430.31 million. At the time of writing, stock’s 50-day Moving Average stood at $5.02, while the 200-day Moving Average is $3.66.
Ovid Therapeutics Inc. (OVID) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Ovid Therapeutics Inc.’s current insider ownership accounts for 41.03%, in contrast to 29.20% institutional ownership. According to the most recent insider trade that took place on Oct 08, this organization’s 10% Owner bought 2,000,000 shares at the rate of 2.50, making the entire transaction reach 5,000,000 in total value, affecting insider ownership by 5,750,000.
Ovid Therapeutics Inc. (OVID) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 3/30/2020, the organization reported -$0.37 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.33) by -$0.04. This company achieved a return on equity of -111.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
Ovid Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 26.90% and is forecasted to reach -1.30 in the upcoming year.
Ovid Therapeutics Inc. (NASDAQ: OVID) Trading Performance Indicators
Let’s observe the current performance indicators for Ovid Therapeutics Inc. (OVID). It’s Quick Ratio in the last reported quarter now stands at 6.10. The Stock has managed to achieve an average true range (ATR) of 0.83.
In the same vein, OVID’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.48, a figure that is expected to reach -0.35 in the next quarter, and analysts are predicting that it will be -1.30 at the market close of one year from today.
Technical Analysis of Ovid Therapeutics Inc. (OVID)
If we take a close look at the recent performances of Ovid Therapeutics Inc. (NASDAQ: OVID), its last 5-days Average volume was 2.87 million that shows progress from its year to date volume of 1.0 million. During the previous 9 days, stock’s Stochastic %D was recorded 60.79% While, its Average True Range was 0.84.
Raw Stochastic average of Ovid Therapeutics Inc. (OVID) in the period of the previous 100 days is set at 77.37%, which indicates a major rise in contrast to 62.45% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 152.20% that was higher than 114.25% volatility it exhibited in the past 100-days period.